Related Experiment Video
Updated: Mar 10, 2026

Noninvasive, High-throughput Determination of Sleep Duration in Rodents
Published on: April 18, 2018
Intraperitoneal cholecystokinin-8 induces atypical somnolence and EEG changes
H Depoortere1, Z De Saint-Hilaire, S Nicolaïdis
1Synthelabo Recherche (L.E.R.S.), Bagneux, France.
Abstract:
EEG sleep recordings were performed in rats after administration of CCK-8. Mildly food-deprived rats were given IP CCK-8 (8 and 16 micrograms/kg body weight) and behavioural as well as EEG changes were examined. With 16 micrograms/kg of CCK-8, there was a significant increase of slow wave sleep in the 30 min of recording. Paradoxical sleep was unchanged or slightly decreased. The low dose of CCK-8 did not promote sleep. In addition both doses of CCK-8 induced EEG alterations including the presence of unusual acute spikes and slowing of EEG rhythm concomitant with awake immobility in rats. The computerized spectral analysis showed that CCK-8 slowed the EEG-wave frequency without modifying the total power energy in comparison with control wakefulness. In contrast, there was no effect in alcuronium-immobilized rats after 8 to 32 micrograms/kg IP of CCK-8. These observations do not support the idea that CCK-8, as a satiating factor like food, would promote sleep.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Management of Insomnia

